Robotic-assisted radical cholecystectomy for the stage Ⅳ gallbladder cancer after adjuvant chemotherapy

doi:10.3877/cma.j.issn.1674-6899.2023.06.010

Abstract

Abstract:

Objective

To investigate the feasibility and safety of robotic-assisted radical cholecystectomy for the stage Ⅳ gallbladder cancer after adjuvant chemotherapy.

Methods

A patient with the stage Ⅳ gallbladder cancer was retrospectively analyzed. After adjuvant chemotherapy with gemcitabine+ oxaliplatin+ carrilizumab, the stage of the gallbladder cancer was significantly reduced, and the robotic-assisted radical cholecystectomy was performed, and the relevant literature was reviewed.

Results

The patients with the stage Ⅳ gallbladder cancer, after adjuvant chemotherapy, the robotic surgery was successfully performed. The operation time was 265 min, the intraoperative blood loss was 50 ml, the postoperative hospital stay was 6 days, and there were no related complications such as bile leakage, bleeding, abdominal infection. Postoperative pathology confirmed a gallbladder adenocarcinoma with negative margins and 17 lymph nodes were removed.

Conclusion

The Ⅳ stage gallbladder cancer, with effective adjuvant chemotherapy, was resected with a small rang specimen and obtained R0. Robotic-assisted radical cholecystectomy has the characteristics of safe and effective surgery, less trauma and quick recovery, etc., and has clinical application prospects.

Key words: Gallbladder cancer, Adjuvant chemotherapy, Robotic-assisted radical cholecystectomy for gallbladder cancer

Dabin Xu, Yanzhe Liu, Xuan Zhang, Rong Liu. Robotic-assisted radical cholecystectomy for the stage Ⅳ gallbladder cancer after adjuvant chemotherapy[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(06): 365-369.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6899.2023.06.010

https://zhqjwkzz.cma-cmc.com.cn/EN/Y2023/V16/I06/365

Figures/Tables 6

References 26

1	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3)：209-249.
2	Roa I, Ibacache G, Muñoz S, et al. Gallbladder cancer in Chile: Pathologic characteristics of survival and prognostic factors: analysis of 1，366 cases[J]. Am J Clin Pathol, 2014, 141(5)：675-682.
3	Shen BY, Zhan Q, Deng XX, et al. Radical resection of gallbladder cancer: could it be robotic？[J]. Surg Endosc, 2012, 26(11)：3245-3250.
4	Tschuor C, Pickens RC, Isenberg EE, et al. Robotic resection of gallbladder cancer: a single-center retrospective comparative study to open resection[J]. Am Surg, 2023, 89(4)：888-896.
5	Byun Y, Choi YJ, Kang JS, et al. Robotic extended cholecystectomy in gallbladder cancer[J]. Surg Endosc, 2020, 34(7)：3256-3261.
6	Byun Y, Choi YJ, Kang JS, et al. Early outcomes of robotic extended cholecystectomy for the treatment of gallbladder cancer[J]. J Hepatobiliary Pancreat Sci, 2020, 27(6)：324-330.
7	Goel M, Khobragade K, Patkar S, et al. Robotic surgery for gallbladder cancer: Operative technique and early outcomes[J]. J Surg Oncol, 2019, 119(7)：958-963.
8	Wu X, Li M, Wu W, et al. Hepatopancreatoduodenectomy for advanced biliary malignancies[J]. Chin Med J (Engl), 2022, 135(23)：2851-2858.
9	Mizuno T, Ebata T, Yokoyama Y, et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer[J]. Br J Surg, 2019, 106(5)：626-635.
10	Javle M, Rashid A, Churi C, et al. Molecular characterization of gallbladder cancer using somatic mutation profiling[J]. Hum Pathol, 2014, 45(4)：701-708.
11	Sinagra E, Garritano S, Iacopinelli SM, et al. Minimally invasive surgical approach for radicalization of incidental post-cholecystectomy gallbladder carcinoma: safety, feasibility and outcomes[J]. Minim Invasive Ther Allied Technol, 2018, 27(4)：217-220.
12	Byun Y, Choi YJ, Kang JS, et al. Robotic extended cholecystectomy in gallbladder cancer[J]. Surg Endosc, 2020, 34(7)：3256-3261.
13	Piccolo G, Ratti F, Cipriani F, et al. Totally laparoscopic radical cholecystectomy for gallbladder cancer: a single center experience[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(6)：741-746.
14	Goel S, Aggarwal A, Iqbal A, et al. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India[J]. World J Gastroenterol, 2021, 27(45)：7813-7830.
15	de Savornin Lohman E, Belkouz A, Nuliyalu U, et al. Adjuvant treatment for the elderly patient with resected gallbladder cancer: a SEER-Medicare analysis[J]. J Gastrointest Oncol, 2022, 13(6)：3227-3239.
16	Chaudhari VA, Ostwal V, Patkar S, et al. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications[J]. HPB (Oxford), 2018, 20(9)：841-847.
17	Takala S, Lassen K, Søreide K, et al. Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers[J]. Scand J Surg, 2023, 112(3)：147-156.
18	Zhang Y, Liu Y, Liu J, et al. Case report: Preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: a report of five cases and a literature review[J]. Front Immunol, 2023, 14：1144371.
19	Zuo B, Yang X, Yang X, et al. A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer[J]. Cancer Immunol Immunother, 2022, 71(8)：1889-1896.
20	Nakanishi H, Miangul S, Oluwaremi TT, et al. Open versus laparoscopic surgery in the management of patients with gallbladder cancer: a systematic review and meta-analysis[J]. Am J Surg, 2022, 224(1 Pt B)：348-357.
21	Han HS, Yoon YS, Agarwal AK, et al. Laparoscopic surgery for gallbladder cancer: an expert consensus statement[J]. Dig Surg, 2019, 36(1)：1-6.
22	Tschuor C, Pickens RC, Isenberg EE, et al. Robotic resection of gallbladder cancer: a single-center retrospective comparative study to open resection[J]. Am Surg, 2023, 89(4)：888-896.
23	Sucandy I, Jabbar F, Syblis C, et al. Robotic central hepatectomy for the treatment of gallbladder carcinoma. outcomes of minimally invasive approach[J]. Am Surg, 2022, 88(3)：348-351.
24	Zhang R, Wu YH, Cai ZQ, et al. Optimal number of harvested lymph nodes for curatively resected gallbladder adenocarcinoma based on a Bayesian network model[J]. J Surg Oncol, 2020, 122(7)：1409-1417.
25	Wang J, Liu F, Ma W, et al. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved[J]. Langenbecks Arch Surg, 2023, 408(1)：382.
26	Zhang R, Wu YH, Zhang D, et al. Analysis of the relationship between the number of lymph nodes examined and prognosis for curatively resected gallbladder carcinoma: a multi-institutional study[J]. Zhonghua Wai Ke Za Zhi, 2020, 58(4)：303-309.

[1]	Yiyong Tang, Xiaoqin Li, Yanyun Shi, Guanglei Fan. Value of ultrasonography combined with mammographic features and Ki-67 index in predicting efficacy of neoadjuvant chemotherapy for breast cancer [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2021, 18(06): 564-569.
[2]	Dan Zhou, Peixian Chen, Wei Li, Shuqing Yang, Kun Zhang, Tiancheng He, Guolin Ye, Aiguo Wu. Correlation between Ki-67 expression change after neoadjuvant chemotherapy and prognosis of HER-2-positive breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2022, 16(03): 167-174.
[3]	Yuhao Zhai, Zhi Zheng, Wei Deng, Zhigang Bai, Jie Yin, Jun Zhang. Advances in the controversies of neoadjuvant chemotherapy for advanced gastric cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(05): 386-390.
[4]	Yun Zhang, Ruikui Zhang, Na Shi, Xiaona Wang, Tiantian Cao, Dongyu Zhao. Construction and validation of prediction model for pathological complete response of patients with advanced gastric cancer after neoadjuvant chemotherapy [J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(04): 282-287.
[5]	Qilu Zhu, Jiayue Zou, Junxi Xiao, Yang Shi. Clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy after neoadjuvant chemotherapy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(02): 200-203.
[6]	Peizhong Shang, Runping Zhang, Wei Zhang, Guohong Jia, Xiaowu Li, Jianjun Miao, Bing Liu. Clinical application of novel techniques for obstructive jaundice prevention and treatment: a single-center study [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 104-107.
[7]	Liqiang Qi. Modified radical resection of left breast cancer after neoadjuvant chemotherapy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 257-257.
[8]	Sijun Cheng, Yumei Yang, Bo Yuan, Jianli Lu, Chao Deng. Selective left hemicolectomy after expandable stent placement to relieve obstruction combined with neoadjuvant chemotherapy in the treatment of obstructive left colon cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(04): 430-433.
[9]	Xiaoting Yu, Zhengren Liu, Yi Xie, Xiaoqing Guo, Jiaheng Huang, Maocheng Fang. Changes and clinical significance of hepatocyte growth factor before and after neoadjuvant chemotherapy for breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(03): 306-309.
[10]	Tao Wu, Junwei He, Ruixing Dai, Jun Pan, Zhaohui Wang, Zunguang Bai. Primary renal undifferentiated pleomorphic sarcoma:a case report and literature review [J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(06): 526-529.
[11]	Ying Du, Lili Cao. Application of neoadjuvant chemotherapy in the treatment of colorectal cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(01): 39-45.
[12]	Fan Yang, Hong Zhang, Jiay Li, Ling Xin, Hongyu Xiang, Qian Liu, Yuanjia Cheng, Jingming Ye, Xuening Duan, Yinhua Liu, Ling Xu, Shuang Zhang. Characteristics of CK5/6 expression in early triple-negative breast cancer: correlation with prognosis and efficacy of neoadjuvant chemotherapy [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1081-1088.
[13]	Junwei Cui, Yinhua Liu, Xiaoling Liu, Yibing Hu, Hui Hu. Efficacy and safety of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1062-1067.
[14]	Qiaoli Guo, Qingzhi Song, Hui Hu. Effiacy of neoadjuvant chemotherapy for different subtypes of breast cancer and factors influencing prognosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(10): 754-759.
[15]	Leilei Shen, Yang Liu. The staging evolution and treatment strategies of stage ⅠB non-small cell lung cancer [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2022, 09(04): 246-254.

Please choose a citation manager

Content to export